Guest guest Posted October 26, 2009 Report Share Posted October 26, 2009 Fellow CLLers, This is great news. Thanks to all who helped make this possible. This is only the beginning. As further experience is gained thru trials and general use, new niches for its best place in treatment with work out. This is a good day for all of us, but we need more. SYK inhibitors, PI3 inhibitors, immunomodulators, and new monoclonals all need to be explored in trials, and the winners need to get to market soon. Some of us don't have 10 years to wait. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.